These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. B7-1 and 4-1BB ligand expression on a myeloma cell line makes it possible to expand autologous tumor-specific cytotoxic T cells in vitro. Lu ZY; Condomines M; Tarte K; Nadal L; Delteil MC; Rossi JF; Ferrand C; Klein B Exp Hematol; 2007 Mar; 35(3):443-53. PubMed ID: 17309825 [TBL] [Abstract][Full Text] [Related]
3. Human decidual stromal cells suppress cytokine secretion by allogenic CD4+ T cells via PD-1 ligand interactions. Nagamatsu T; Schust DJ; Sugimoto J; Barrier BF Hum Reprod; 2009 Dec; 24(12):3160-71. PubMed ID: 19729380 [TBL] [Abstract][Full Text] [Related]
4. Role of interleukin 16 in multiple myeloma. Atanackovic D; Hildebrandt Y; Templin J; Cao Y; Keller C; Panse J; Meyer S; Reinhard H; Bartels K; Lajmi N; Sezer O; Zander AR; Marx AH; Uhlig R; Zustin J; Bokemeyer C; Kröger N J Natl Cancer Inst; 2012 Jul; 104(13):1005-20. PubMed ID: 22745469 [TBL] [Abstract][Full Text] [Related]
5. Myeloma Drug Resistance Induced by Binding of Myeloma B7-H1 (PD-L1) to PD-1. Ishibashi M; Tamura H; Sunakawa M; Kondo-Onodera A; Okuyama N; Hamada Y; Moriya K; Choi I; Tamada K; Inokuchi K Cancer Immunol Res; 2016 Sep; 4(9):779-88. PubMed ID: 27440711 [TBL] [Abstract][Full Text] [Related]
6. Induced expression of B7-1 on myeloma cells following retroviral gene transfer results in tumor-specific recognition by cytotoxic T cells. Tarte K; Zhang XG; Legouffe E; Hertog C; Mehtali M; Rossi JF; Klein B J Immunol; 1999 Jul; 163(1):514-24. PubMed ID: 10384156 [TBL] [Abstract][Full Text] [Related]
7. Human umbilical cord blood-derived stromal cells: a new resource for the proliferation and apoptosis of myeloma cells. Gao L; Zhang C; Zhang X; Gao L; Hao L; Chen XH Hematology; 2014 Apr; 19(3):148-57. PubMed ID: 23896383 [TBL] [Abstract][Full Text] [Related]
8. A major role for Mcl-1 antiapoptotic protein in the IL-6-induced survival of human myeloma cells. Jourdan M; Veyrune JL; De Vos J; Redal N; Couderc G; Klein B Oncogene; 2003 May; 22(19):2950-9. PubMed ID: 12771946 [TBL] [Abstract][Full Text] [Related]
9. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Dong H; Strome SE; Salomao DR; Tamura H; Hirano F; Flies DB; Roche PC; Lu J; Zhu G; Tamada K; Lennon VA; Celis E; Chen L Nat Med; 2002 Aug; 8(8):793-800. PubMed ID: 12091876 [TBL] [Abstract][Full Text] [Related]
10. Fas (APO-1/CD95)-mediated apoptosis is independent of bcl-2: a study with cell lines overexpressing bcl-2 and with bcl-2 transfected cell lines. Gazitt Y; Hu WX Int J Oncol; 1998 Jan; 12(1):211-20. PubMed ID: 9454907 [TBL] [Abstract][Full Text] [Related]
11. B7-H1 and B7-DC receptors of oral squamous carcinoma cells are upregulated by Porphyromonas gingivalis. Groeger S; Domann E; Gonzales JR; Chakraborty T; Meyle J Immunobiology; 2011 Dec; 216(12):1302-10. PubMed ID: 21723642 [TBL] [Abstract][Full Text] [Related]
12. The RANK/RANK ligand system is involved in interleukin-6 and interleukin-11 up-regulation by human myeloma cells in the bone marrow microenvironment. Giuliani N; Colla S; Morandi F; Rizzoli V Haematologica; 2004 Sep; 89(9):1118-23. PubMed ID: 15377473 [TBL] [Abstract][Full Text] [Related]
13. Costimulatory molecule expression on human uveal melanoma cells: functional analysis of CD40 and B7-H1. Ma J; Usui Y; Kezuka T; Okunuki Y; Zhang L; An X; Mizota A; Goto H Exp Eye Res; 2012 Mar; 96(1):98-106. PubMed ID: 22200489 [TBL] [Abstract][Full Text] [Related]
14. Etodolac induces apoptosis and inhibits cell adhesion to bone marrow stromal cells in human myeloma cells. Nakamura S; Kobayashi M; Shibata K; Sahara N; Shigeno K; Shinjo K; Naito K; Hayashi H; Ohnishi K Leuk Res; 2006 Feb; 30(2):123-35. PubMed ID: 16046235 [TBL] [Abstract][Full Text] [Related]
15. Induced B7-H1 expression on human renal tubular epithelial cells by the sublytic terminal complement complex C5b-9. Chen Y; Zhang J; Guo G; Ruan Z; Jiang M; Wu S; Guo S; Fei L; Tang Y; Yang C; Jia Z; Wu Y Mol Immunol; 2009 Jan; 46(3):375-83. PubMed ID: 19081139 [TBL] [Abstract][Full Text] [Related]
16. Chemosensitization of myeloma plasma cells by an antisense-mediated downregulation of Bcl-2 protein. van de Donk NW; Kamphuis MM; van Dijk M; Borst HP; Bloem AC; Lokhorst HM Leukemia; 2003 Jan; 17(1):211-9. PubMed ID: 12529680 [TBL] [Abstract][Full Text] [Related]
17. FTY720 induces apoptosis in multiple myeloma cells and overcomes drug resistance. Yasui H; Hideshima T; Raje N; Roccaro AM; Shiraishi N; Kumar S; Hamasaki M; Ishitsuka K; Tai YT; Podar K; Catley L; Mitsiades CS; Richardson PG; Albert R; Brinkmann V; Chauhan D; Anderson KC Cancer Res; 2005 Aug; 65(16):7478-84. PubMed ID: 16103102 [TBL] [Abstract][Full Text] [Related]
18. Effect of Cx43 gene-modified leukemic bone marrow stromal cells on the regulation of Jurkat cell line in vitro. Zhang X; Liu Y; Si YJ; Chen XH; Li ZJ; Gao L; Gao L; Zhang C Leuk Res; 2012 Feb; 36(2):198-204. PubMed ID: 22030334 [TBL] [Abstract][Full Text] [Related]
19. Bone marrow stromal-derived soluble factors and direct cell contact contribute to de novo drug resistance of myeloma cells by distinct mechanisms. Nefedova Y; Landowski TH; Dalton WS Leukemia; 2003 Jun; 17(6):1175-82. PubMed ID: 12764386 [TBL] [Abstract][Full Text] [Related]
20. Functional significance of B7-H1 expressed by human uveal melanoma cells. Jia R; Jiao Z; Xu X; Wang J; Zhou Y; Song X; Ge S; Fan X Mol Med Rep; 2011; 4(1):163-7. PubMed ID: 21461580 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]